How often are Remicade (infliximab) infusions scheduled for Crohn’s?
For Crohn’s disease, Remicade infusions are typically given on a fixed timetable based on induction and then maintenance dosing. In many standard regimens, patients receive infusions every 8 weeks after the initial start period (with the exact start schedule set by the prescribing clinician).
What does the usual induction-to-maintenance schedule look like?
The common pattern is:
- Induction phase: multiple infusions early on to bring the disease under control (the exact first-month schedule is set by the treatment plan).
- Maintenance phase: after induction, infusions are usually spaced farther apart, commonly to every 8 weeks.
What might change the infusion frequency?
Clinicians may shorten the interval (for example, to more frequent dosing) if Crohn’s symptoms return or if blood levels of infliximab are low. Dosing can also be adjusted if a patient develops certain safety concerns or side effects.
How long does it take to get to the “every 8 weeks” routine?
Patients typically move from the initial induction infusions into a maintenance schedule after the early induction period. After that transition, the maintenance interval is often set to every 8 weeks, but the exact timing depends on the individual’s prescribed regimen and response.
Who decides the schedule and how is it monitored?
The treating gastroenterologist sets the schedule and monitors response using a mix of symptom tracking and clinical/lab assessments. If the regimen isn’t controlling Crohn’s well, the infusion interval may be adjusted.
Sources
I’m missing the specific dosing schedule details from the provided materials. If you share the dosing guidance you were given (or whether you mean adult vs pediatric Crohn’s, and maintenance only vs induction + maintenance), I can restate the schedule precisely.